The Rohrabacher-Leahy Amendment says the U.S. Department of Justice cannot use federal dollars to prosecute state-licensed cannabis businesses.
Quietly passed with the controversial 2018 omnibus appropriations package, a $1.3 trillion congressional spending bill, was the Rohrabacher-Leahy Amendment, which restored protection of medical cannabis cultivators from federal prosecution.
The amendment says the U.S. Department of Justice cannot use federal dollars to prosecute state-licensed cannabis cultivators, distributors and licensees operating in compliance with state laws, despite cannabis still being considered a schedule-one drug and illegal on a federal level.
George Scorsis, director and CEO of Toronto, Canada-based Liberty Health Sciences, which has slowly started building its medical cannabis empire in Alachua County, told the Sun this restored protection is important for an industry that is steadily growing, but also for the patients that benefit from their products.
“We have a high level of comfort that the government will not